Combined Blood Stem Cell and Kidney Transplant of One Haplotype Match Living Donor Pairs. Post author: Post published:April 20, 2026 Post category: Continue ReadingCombined Blood Stem Cell and Kidney Transplant of One Haplotype Match Living Donor Pairs.
Safety and Tolerability of IMM01-STEM in Patients With Muscle Atrophy Related to Knee Osteoarthritis. Post author: Post published:April 20, 2026 Post category: Continue ReadingSafety and Tolerability of IMM01-STEM in Patients With Muscle Atrophy Related to Knee Osteoarthritis.
A Phase 1/2 Trial of ADI-270 in ccRCC Post author: Post published:April 20, 2026 Post category: Continue ReadingA Phase 1/2 Trial of ADI-270 in ccRCC
A Phase 1/2/3 Study of UX701 Gene Therapy in Adults With Wilson Disease Post author: Post published:April 20, 2026 Post category: Continue ReadingA Phase 1/2/3 Study of UX701 Gene Therapy in Adults With Wilson Disease
Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-251 in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping Post author: Post published:April 20, 2026 Post category: Continue ReadingSafety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-251 in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping
Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis Post author: Post published:April 20, 2026 Post category: Continue ReadingComparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis
Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) Post author: Post published:April 20, 2026 Post category: Continue ReadingPhase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)
Treatment of Moderate to Severe Refractory Crohn’s Disease Post author: Post published:April 20, 2026 Post category: Continue ReadingTreatment of Moderate to Severe Refractory Crohn’s Disease
A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression Post author: Post published:April 20, 2026 Post category: Continue ReadingA Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
A Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of mRNA-3705 in Participants With Isolated Methylmalonic Acidemia Post author: Post published:April 20, 2026 Post category: Continue ReadingA Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of mRNA-3705 in Participants With Isolated Methylmalonic Acidemia
